Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-03-30 4:43 pm Purchase | 13G | HARPOON THERAPEUTICS INC HARP | New Leaf Ventures III L.P. | 6,248,469 15.4% | 2,994,305 (+92.01%) | View |
| 2023-03-29 4:27 pm Purchase | 13D | HARPOON THERAPEUTICS INC HARP | Arix Bioscience plc | 3,238,929 8.4% | 1,048,007 (+47.83%) | View |
| 2023-02-14 4:25 pm Sale | 13G | HARPOON THERAPEUTICS INC HARP | ORBIMED ADVISORS LLC | 804,206 2.4% | -863,694 (-51.78%) | View |
| 2023-02-06 4:32 pm Purchase | 13G | HARPOON THERAPEUTICS INC HARP | New Leaf Ventures III L.P. | 3,254,164 9.8% | 42,309 (+1.32%) | View |
| 2023-01-18 4:16 pm Purchase | 13G | HARPOON THERAPEUTICS INC HARP | INTEGRATED CORE STRATEGIES (US) LLC | 1,970,274 5.9% | 1,970,274 (New Position) | View |
| 2022-07-08 4:56 pm Sale | 13G | HARPOON THERAPEUTICS INC HARP | BlackRock Inc. BLK | 940,475 2.8% | -773,856 (-45.14%) | View |
| 2022-02-15 08:37 am Sale | 13G | HARPOON THERAPEUTICS INC HARP | Logos Global Management LP | 1,500,000 4.6% | -330,000 (-18.03%) | View |
| 2022-02-11 4:58 pm Purchase | 13G | HARPOON THERAPEUTICS INC HARP | New Leaf Ventures III L.P. | 3,211,855 9.8% | 285,527 (+9.76%) | View |
| 2022-02-11 4:26 pm Purchase | 13G | HARPOON THERAPEUTICS INC HARP | ORBIMED ADVISORS LLC | 1,667,900 5.1% | 647,196 (+63.41%) | View |
| 2022-02-04 4:12 pm Purchase | 13G | HARPOON THERAPEUTICS INC HARP | BlackRock Inc. BLK | 1,714,331 5.2% | 319,025 (+22.86%) | View |
| 2021-12-27 5:25 pm Purchase | 13G | HARPOON THERAPEUTICS INC HARP | Logos Global Management LP | 1,830,000 5.6% | 1,830,000 (New Position) | View |
| 2021-07-15 5:41 pm Sale | 13D | HARPOON THERAPEUTICS INC HARP | Arix Bioscience plc | 2,190,922 6.7% | -17,745 (-0.80%) | View |
| 2021-05-06 06:15 am Sale | 13D | HARPOON THERAPEUTICS INC HARP | MPM BioVentures 2014 L.P. | 6,561,458 20.2% | -575,270 (-8.06%) | View |
| 2021-02-16 08:30 am Sale | 13D | HARPOON THERAPEUTICS INC HARP | MPM BioVentures 2014 L.P. | 7,136,728 22.3% | -1,286,119 (-15.27%) | View |
| 2021-02-12 4:49 pm Sale | 13G | HARPOON THERAPEUTICS INC HARP | ORBIMED ADVISORS LLC | 1,020,704 4.02% | -340,000 (-24.99%) | View |
| 2021-02-10 3:04 pm Purchase | 13G | HARPOON THERAPEUTICS INC HARP | BlackRock Inc. BLK | 1,395,306 4.4% | 31,094 (+2.28%) | View |
| 2021-02-02 3:13 pm Purchase | 13G | HARPOON THERAPEUTICS INC HARP | BlackRock Inc. BLK | 1,364,212 5.4% | 1,364,212 (New Position) | View |
| 2021-01-12 4:15 pm Purchase | 13D | HARPOON THERAPEUTICS INC HARP | Arix Bioscience plc | 2,208,667 6.9% | 14,963 (+0.68%) | View |
| 2020-06-01 5:00 pm Sale | 13D | HARPOON THERAPEUTICS INC HARP | Arix Bioscience plc | 2,193,704 8.8% | -415,213 (-15.92%) | View |
| 2020-02-12 5:47 pm Purchase | 13G | HARPOON THERAPEUTICS INC HARP | New Leaf Ventures III L.P. | 2,926,328 11.9% | 4,923 (+0.17%) | View |